Access reviews positive interim outcomes from MuGard Phase 4 clinical trial in oral mucositis ACCESS PHARMACEUTICALS, INC. , a biopharmaceutical firm leveraging its proprietary drug-delivery platforms to develop treatments in regions of oncology and oncology supportive care, announced interim outcomes from its ongoing MuGard Stage 4 scientific trial in oral mucositis sildenafil citrate . An interim evaluation from the first forty patients enrolled in the trial demonstrated that individuals using MuGard experienced a statistically significant decrease in mouth and throat soreness and a decrease in the usage of opioid pain medication compared to individuals in the control arm. The trial can be continuing to enroll patients and Access anticipates presenting clinical data at a respected oncology supportive care meeting come early july.
Accommodations for Dyslexia Later in school life, and in adulthood, the focus is on accommodations. This means that reasonable attempts must be made to adapt the curriculum and method of instruction to allow the individual with dyslexia to make use of alternative strategies for a given task. These accommodations are often requested beneath the Individualized Education Strategy ; yet, in some instances they may be applied under a section 504 strategy under American with Disabilities Take action without the procedural safeguards of an IEP. Some types of accommodations consist of: instructional, environmental, testing, assignment/homework, and/or assistive technology There are great resources and in print regarding information on the above online, but a few good examples are provided here: Adjust reading level Allow college student to tape lectures Allow word-processed or typewritten assignments Give a written outline Seat student near instructor Provide a structured schedule in written type Provide organizational strategies such as charts, timelines, binders for components etc.